FE International acted as the exclusive M&A advisor to Vidello, ensuring a seamless transaction aligned with both parties’ strategic objectives. For more information about FE International and its ...
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 ...
Innovative technology digitizes up to 1,500 tissue samples daily, supporting quick and accurate diagnosis by pathologists Epredia, a global leader in precision cancer diagnostics and subsidiary of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results